Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sample.

Moons T, De Hert M, Kenis G, Viechtbauer W, van Os J, Gohlke H, Claes S, van Winkel R.

Pharmacogenomics. 2014 May;15(7):951-62. doi: 10.2217/pgs.14.46.

PMID:
24956249
2.
3.

Reduced adult hippocampal neurogenesis and working memory deficits in the Dgcr8-deficient mouse model of 22q11.2 deletion-associated schizophrenia can be rescued by IGF2.

Ouchi Y, Banno Y, Shimizu Y, Ando S, Hasegawa H, Adachi K, Iwamoto T.

J Neurosci. 2013 May 29;33(22):9408-19. doi: 10.1523/JNEUROSCI.2700-12.2013.

4.

Epigenetic and genetic variation at the IGF2/H19 imprinting control region on 11p15.5 is associated with cerebellum weight.

Pidsley R, Dempster E, Troakes C, Al-Sarraj S, Mill J.

Epigenetics. 2012 Feb;7(2):155-63. doi: 10.4161/epi.7.2.18910.

5.

Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (Gsk-3) regulates DNA methylation of imprinted loci.

Popkie AP, Zeidner LC, Albrecht AM, D'Ippolito A, Eckardt S, Newsom DE, Groden J, Doble BW, Aronow B, McLaughlin KJ, White P, Phiel CJ.

J Biol Chem. 2010 Dec 31;285(53):41337-47. doi: 10.1074/jbc.M110.170704. Epub 2010 Nov 3.

6.

Early life protein restriction alters dopamine circuitry.

Vucetic Z, Totoki K, Schoch H, Whitaker KW, Hill-Smith T, Lucki I, Reyes TM.

Neuroscience. 2010 Jun 30;168(2):359-70. doi: 10.1016/j.neuroscience.2010.04.010. Epub 2010 Apr 13.

Supplemental Content

Loading ...
Support Center